04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
Seyfarth Synopsis: Maryland has expanded employer liability for workplace harassment this week. Leg...
Read More >
Since the enactment of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) on...
Read More >
Eleventh Circuit Affirms “Exceptional Case” Ruling: Insurer Had No Duty to Defend Construction Deb...
Read More >
The California Legislature passed a closely watched bill on September 11, 2019 that, if signed into ...
Read More >
Romania’s fertility rate is statistically low, with only 1.54 children born per woman in 2018. The ...
Read More >
We analyzed the terms of 189 venture financings closed in the third quarter of 2019 by companies hea...
Read More >